REVIVA PHARMACEUTICALS HOLDINGS, INC. (NASDAQ:RVPH) filed a Form 8-K with the Securities and Exchange Commission on January 23, 2026, disclosing a material event.
REVIVA PHARMACEUTICALS HOLDINGS, INC.'s stock currently trades at $0.33 with a market capitalization of $46.5M. The Healthcare company's stock moved following the disclosure.